期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

神经母细胞瘤治疗进展 被引量：9

暂未订购
导出
摘要 神经母细胞瘤（neuroblastoma,NB）来源于肾上腺髓质或交感神经节,是儿童最常见的颅外实体肿瘤,年发病率约0.3/10万-5.5/10万,占儿童肿瘤的7%-8%。NB占因肿瘤致死的儿童15%-（[1]）。我国流行病学资料显示,NB的发病率呈上升趋势,每年新诊约3000例,仅次于白血病及中枢神经系统肿瘤疾病。由于其恶性程度高、易发生转移等特点,约70%-80%的患者确诊时已是晚期（Ⅲ期或Ⅳ期）,预后差。近20年来,国际上对儿童NB的治疗已形成较为规范的诊疗指南,国内肿瘤学组也初步达成专家共识,低-中危组患儿能获得良好预后,
作者 杨婷 胡显良 王珊
机构地区 重庆医科大学附属儿童医院肿瘤外科 重庆医科大学附属成都市妇女儿童中心医院儿外科
出处 《中国小儿血液与肿瘤杂志》 CAS 2015年第6期329-332,共4页 Journal of China Pediatric Blood and Cancer
关键词 神经母细胞瘤 NEUROBLASTOMA 肿瘤学 实体肿瘤 交感神经节 预后差 儿童肿瘤 肾上腺髓质 专家共识 恶性程度
分类号 R739.4 [医药卫生—肿瘤]
  • 相关文献

参考文献26

  • 1Haupt R, Garaventa A, Gambini C, et al. Improved survival of children with neurohlastoma between 1997 and 2005 : A report of the halian neuroblastoma registry. Clin Oncol, 2010, 28 : 2331-2338.
  • 2Pandey GK, Kandul'i C. Long noncoding RNAs and neuroblastoma. Oncotarget, 2015,6 : 18265-18275.
  • 3Castel V, Grau E, Noguera R, et al. Molecular biology of neuroblastoma. Clin transl oncol, 2007, 9 : 478-483.
  • 4Buechner J, Einvik C. N-myc and noncoding RNAs in neuroblastoma. Mol Cancer Res, 2012, 10 : 1243-1253.
  • 5Cohn SL, Pearson AD, London WB, et al. The International Neuroblastoma Risk Group (INGR) classification system: an INGR Task Force report. J Clin Oncol, 2009, 27:289-297.
  • 6Rich BS, McEvoy MP, Kelly NE,et al. Resectahility and operative morbidity after chemotherapy in neuroblastoma patients with encasement of major visceral. J Pediatr Surg, 2011, 46 : 103-107.
  • 7李忠元,赵强,王景福,曹嫣娜,李璋琳,闫杰.100例神经母细胞瘤临床预后分析[J].中国肿瘤临床,2011,38(3):155-158. 被引量：15
  • 8Moon SB, Park KW, Jung SE, et al. Neuroblastoma: treatment outcome after incomplete resection of primary tumors. Pdeiatr Surg Int, 2009, 25: 789-793.
  • 9江启俊.外科治疗神经母细胞瘤的世纪回顾及展望[J].中华小儿外科杂志,2000,21(3):137-138. 被引量：5
  • 10Warmann SW, Seitz G, Schaefer JF, et al. Vascular encasement as element of risk stratification in abdominal neuroblastoma. Surg Oncol, 2011, 20:231-235.

二级参考文献32

  • 1黄东生,唐锁勤,王建文,刘英,刘立真,扬光,吕善根.CEM方案预处理结合自体外周血干细胞移植治疗晚期神经母细胞瘤5例观察[J].中国实用儿科杂志,2004,19(9):532-534. 被引量：13
  • 2唐锁勤,黄东生,王建文,冯晨,杨光.大剂量化疗造血干细胞移植治疗IV期神经母细胞瘤的长期疗效研究[J].中国当代儿科杂志,2006,8(2):93-96. 被引量：27
  • 3高晓宁,唐锁勤,林季.晚期儿童神经母细胞瘤的临床和预后分析[J].中国当代儿科杂志,2007,9(4):351-354. 被引量：7
  • 4Brodeur GM,Pritchard J,Berthold F,et al.Revisions of the international criteria for neuroblastoma diagnosis,staging,and response to treatment[J].J Clin Oncol,1993,11(8):1466-1477.
  • 5LondonWB,Boni L,Simon T,et al.The role of age in neuroblastoma risk stratification:the German,Italian,and children's oncology group perspectives[J].Cancer Lett,2005,228(1-2):257-266.
  • 6Pearson AD,Pinkerton CR,Lewis IJ,et al.High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma:a randomised trial[J].Lancet Oncol,2008,9(3):247-256.
  • 7Ryu KH,Ahn HS,Koo HH,et al.Autologous stem cell transplantation for the treatment of neuroblastoma in Korea[J].J Korean Med Sci,2003,18(2):242-247.
  • 8Pritchard J,Cotterill SJ,Germond SM,et al.High dose melphalan in the treatment of advanced neuroblastoma:results of a randomised trial(ENSG-1)by the European Neuroblastoma Study Group[J].Pediatr Blood Cancer,2005,44(4):348-357.
  • 9Fish JD,Grupp SA.Stem cell transplantation for neuroblastoma[J].Bone Marrow Transplant,2008,41(2):159-165.
  • 10Nagai J,Yazawa T,Okudela K,et al.Retinoic add induces neuroblastoma cell death by inhibiting proteasomal degradation of retinoic acid receptor alpha[J].Cancer Res,2004,64(21):7910-7917.

共引文献22

同被引文献70

  • 1郑漪,李芳,郑传经,余佳宁,梁丽俊,潘月英.小儿神经母细胞瘤17例报告[J].中国小儿血液与肿瘤杂志,2006,11(6):305-307. 被引量：1
  • 2张信平.转移性结肠癌药物治疗的研究进展[J].中国新药与临床杂志,2007,26(11):868-872. 被引量：5
  • 3Haupt R, Garaventa A, Garnbini C, et al. Improved survival of chil- dren with neuroblastoma between 1979 and 2005 :a report of the Ital- ian Neuroblastoma Registry [ J 1. J Clin Oncol, 2010,28 ( 14 ) : 2331 - 2338. DOI: 10. 1200/JCO. 2009.24. 8351.
  • 4Mandel M, Rechavi G, Neumann Y, et al. Bone marrow cell popula- tions mimicking common acute lymphoblastic leukemia in infants with stage IV-S neuroblastoma[ J]. Acta Haematol,1991,86(2) :86-89.
  • 5Castleberry RP, Shuster JJ, Smith El. The Pediatric Oncology Group experience with the international staging system criteria for neuroblas- toma. Member Institutions of the Pediatric Oncology Group [J]. J Clin Oncol, 1994,12( 11 ) :2378-2381.
  • 6Shimada H, Ambros IM, Dehner LP, et al. The International Neuro- blastoma Pathology Classification( the Shimada system) [J]. Cancer, 1999,86(2) :364-372.
  • 7师英强,金百祥.尿VMA、HVA测定与神经母细胞瘤[J].国际外科学杂志,1984(2):86-89.
  • 8Haupt R,Garaventa A C, Parodi S, et al. Improvedsurvival of children with neuroblastoma between 1979and 2005 : a report of the Italian Neuroblastoma Registry[J]. J Clin Oncol,2010,28( 14) :2331-8.
  • 9Adeline S, Dhanya M,Barry P, et al. Neuroblastoma:a 20-year experience in a UK regional centre [ J ]. Pedi-atric Blood Cancer,2011,57(7) : 1254-1260.
  • 10Hegde S R,Weijing S,Lynch J P. Systemic and targe-ted therapy for advanced colon cancer[ J]. Expert RevGastroenterol Hepatol, 2014,2( 1) :l35-49.

引证文献9

二级引证文献39

中国小儿血液与肿瘤杂志
2015年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部